Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 711–712 | Cite as

Blood Transfusion in Cytoreductive Surgery: Better Not at All

  • Eran NizriEmail author
  • Shigeki Kusamura
  • Marcello Deraco
ASO Author Reflections



There are no conflicts of interest.


  1. 1.
    Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg. 2012;256:235–44.CrossRefGoogle Scholar
  2. 2.
    Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006(1):CD005033.Google Scholar
  3. 3.
    Saxena A, Valle SJ, Liauw W, Morris DL. Allogenic blood transfusion is an independent predictor of poorer perioperative outcomes and reduced long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of 936 cases. J Gastrointest Surg. 2017;21:1318–27.CrossRefGoogle Scholar
  4. 4.
    Saxena A, Yan TD, Chua TC, et al. Risk factors for massive blood transfusion in cytoreductive surgery: a multivariate analysis of 243 procedures. Ann Surg Oncol. 2009;16:2195–203.CrossRefGoogle Scholar
  5. 5.
    Nizri E, Kusamura S, Fallabrino G, Guaglio M, Baratti D, Deraco M. Dose-dependent effect of red blood cells transfusion on perioperative and long-term outcomes in peritoneal surface malignancies treated with cytoreduction and HIPEC. Ann Surg Oncol. 2018;25:3264–70.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Eran Nizri
    • 1
    • 2
    Email author
  • Shigeki Kusamura
    • 2
  • Marcello Deraco
    • 2
  1. 1.Division of Surgery, Department of Surgery A, Tel-Aviv Sourasky Medical Center and Sackler Faculty of MedicineTelAviv UniversityTel-AvivIsrael
  2. 2.Peritoneal Surface Malignancies Unit, Colon and Rectal SurgeryFondazione IRCCS Istituto Nazionale dei TumoriMilanItaly

Personalised recommendations